SHANA CALDWELL: Open Payments
NPI 1578166971 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 58 payments from 19 companies in 2025. Trend: 2023 $1,163 · 2024 $1,539 · 2025 $1,759
Food & beverage: $1,759
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $677 |
| AstraZeneca Pharmaceuticals LP | 6 | $279 |
| ABBVIE INC. | 1 | $111 |
| Daiichi Sankyo Inc. | 4 | $87 |
| Astellas Pharma US Inc | 5 | $74 |
| Medtronic, Inc. | 2 | $74 |
| Lilly USA, LLC | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| PFIZER INC. | 3 | $52 |
| Noven Therapeutics, LLC | 3 | $50 |
Products named: Ozempic, Wegovy, BREZTRI, QULIPTA, INJECTAFER, Rybelsus, Veozah, MOUNJARO.
Industry payments across FL — which companies pay providers there.
